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ABSTRACT  Neff et al. (1982, J. Cell Biol., 95:654-666) have described a monoclonal antibody, 
CSAT, directed  against  a  cell  surface  antigen  that  participates  in  the  adhesion  of  skeletal 
muscle  to  extracellular  matrices.  We  used  the  same  antibody  to  compare  and  parse  the 
determinants of adhesion and morphology on myogenic and fibrogenic cells. We report here 
that the antigen  is present on skeletal  and  cardiac  muscle  and  on tendon,  skeletal,  dermal, 
and cardiac fibroblasts; however, its contribution to their morphology and adhesion is different. 
The antibody produces large alterations in the morphology and adhesion of skeletal  myoblasts 
and tendon fibroblasts; in contrast, its effects on the cardiac fibroblasts are not readily detected. 
The  effects  of  CSAT  on  the  other  cell  types,  i.e.,  dermal  and  skeletal  fibroblasts,  cardiac 
muscle, 5-bromodeoxyuridine-treated  skeletal muscle,  lie between these extremes. The effects 
of  CSAT  on  the  skeletal  myoblasts  depends  on  the  calcium  concentration  in  the  growth 
medium and on the culture age. We interpret these differential responses to CSAT as revealing 
differences in the adhesion of the various cells to extracel[ular matrices.  This interpretation  is 
supported by parallel  studies  using quantitative assays of cell-matrix adhesion. The likely origin 
of these adhesive differences  is the progressive  display of different kinds of adhesion-related 
molecules  and their organizational  complexes  on increasingly adhesive  cells.  The antigen to 
which CSAT is directed  is present on all of the above cells  and thus appears  to be a lowest 
common denominator of their adhesion to extracellular matrices. 
Adhesive differences among embryonic cells are thought to 
play a  prominent  role  in  directing  morphogenesis (2,  32). 
Numerous examples of such differential adhesions have been 
described and evidence has been presented that relates them 
to morphogenic phenomena.  The  histotypic sorting out of 
embryonic cells is rationalized as reflecting the graded, differ- 
ential adhesive interactions of the constituent cells (24,  26, 
30,  31). In the nervous system, the high specificity of retino- 
tectal  interactions  appears to  reflect the  adhesive gradients 
generated by the retinal and tectal cells (12, 24). The migration 
of neuronal processes to their peripheral targets is also highly 
specific and is hypothesized to reflect the differential affinities 
of the processes for extracellular substrates (7, 23). 
Recently membrane proteins have been identified and iso- 
lated using adhesion-perturbing monoclonal antibodies whose 
antigens localize in the region of cell-substratum adhesions 
(13, 27, 28). One of these antibodies, called CSAT, is directed 
against an antigen that participates in the adhesion of embry- 
onic skeletal muscle to extracellular matrices (17,  18,  27). T 
The  active  determinant  appears to  be  part  of an  integral 
membrane protein complex located in the vicinity of trans- 
membrane assemblies involved in adhesion.  The identifica- 
tion of such adhesion-related molecules allows an investiga- 
tion of their role in regulating the adhesion and morphology 
of different cell types. Here we describe the effects of CSAT 
on the morphology and matrix adhesion of a group of avian 
embryonic  cells.  We  find  that  the  antigen  is  present  on 
skeletal,  cardiac,  and  5-bromodeoxyuridine (BrdU)-treated 
skeletal myoblasts and on skeletal, tendon, dermal, and car- 
diac fibroblasts. The effect of the antibody on their adhesion, 
however, is different and characteristic. The tendon fibroblasts 
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fibroblasts lie near the other. The morphology and adhesion 
of the former are perturbed markedly by CSAT; the latter in 
contrast are  not  altered  detectably. These  observations are 
interpreted as revealing a hierarchy of morphologic and ad- 
hesive determinants (10,  16). We hypothesize that this hier- 
archy arises from a progressive display of additional adhesion- 
related  molecules and their organization  complexes on  in- 
creasingly adhesive cells. 
MATERIALS  AND  METHODS 
Avian Cell Cultures:  Skeletal  muscle cultures were explanted, disso- 
ciated,  and  cultured  as described  elsewhere, except  that chicken  egg white 
Conalbumin (Sigma Type II, iron complex) replaced the chick embryo extract 
(27). The dissociated cells were plated onto Falcon tissue culture dishes (Falcon 
Labware, Oxnard,  CA) coated with 0.1% gelatin (BBL Microbiology Systems, 
Cockeysville, MD) at a density of 3.5 x  l0  s cells per 35-mm dish. 0.2--0.3 mM 
EGTA was added  to  calcium-free  medium to  prevent  fusion  of myoblast 
cultures; otherwise the cells were grown in normal (1.8 raM) calcium concen- 
trations.  BrdU-treated  myoblasts  were grown similarly except  that the cells 
were plated in medium containing  BrdU at a concentration  of 1.6 x  10  4  M 
and was readded  either  everyday  or every other day to cultures  growing in 
normal calcium concentrations. 
Cardiac myoblasts were prepared as described by DeHaan (11) from 7-d-old 
embryonic heart ventricles. The cells were plated at a density of 5 x  10S/ml on 
0.1% gelatin coated  Falcon  tissue culture  dishes and cultured  in Dulbecco's 
modified Eagle's medium (DME)  2 containing  10% horse serum and  1% con- 
albumin. 
Skeletal fibroblasts were prepared from preplates of myogenic cultures (28). 
The cultures  were  grown in  DME  containing  5-10%  fetal  calf serum on 
uncoated tissue culture dishes and used between the third and seventh passages. 
Tendon flbroblasts were obtained  from 15-18-d-old embryos. After decapi- 
tation,  the lower leg was removed  at the knee and placed into calcium-  and 
magnesium-free phosphate-buffered saline (CMF-PBS). The toes were partially 
cut; the tendons were freed at the knee joint and then removed by pulling at 
the toes. The isolated tendons were incubated  for 40 min at 37"C in 1 mg/ml 
collagenase (CLS II [Worthington  Biochemicals,  Freehold,  NJ]) and 0.25% 
trypsin (Gibco Laboratories,  Grand Island, NY). After trituation  by pipetting 
with a flamed pasteur pipette, the dissociated cells were spun for 5 min at 180 
gand resuspended into DME with 10% fetal calf sernm and plated onto Falcon 
tissue culture dishes at a density of 5 ×  105 cells/ml.  The cells were passaged 
two times before seeding in 35 mm dishes at a density of 3-5 x  104 cells/dish 
in DME containing 0-20% serum. 
Dermal and cardiac fibroblasts were isolated from the back skin of 13-15- 
d-old embryos and from 14-d-old embryo ventricles, respectively, as described 
by Conrad et al. (9). The dermal fibroblast cultures were pass,aged up to three 
times and the  cardiac  fibroblasts  were  used  after  two passages. They were 
cultured in DME containing  5-10%  fetal calf sernm. 
Adhesion Assay':  Cardiac and tendon fibroblasts were prepared  and 
grown as described above. The cells were passaged at least three times before 
use. 48-h cultures,  at a confluency  of 75-85%,  were washed two times with 
CMF-PBS with 0.02% EDTA and incubated for 10 min (tendon fibroblasts) or 
30 min (cardiac fibroblasts) in 0.02% EDTA in calcium- and magnesium-free 
HEPES-Hank's  (CMF-HH).  The rounded cells were harvested by gentle pipet- 
ting using a fire polished Pasteur pipette and centrifuged at 160 g for 3--4 rain. 
The ceils were resuspended  into DME containing  2% bovine serum albumin 
and 20 mM HEPES (or into conditioned  medium with 20 mM HEPES), and 
the cell density adjusted to 9. x  104 cells/ml. Viability was estimated using 0.4% 
trypan blue. Cell suspensions with viability <80% were not used.  1.8 ml were 
aliquoted  into Linbro tissue culture  vinyl multiwells or multiwell disposable 
trays (Flow Laboratories, Inc., McLean, VA [catalog #76-000-04 and #76-000- 
05]). The wells were sealed with plastic cell cover sheets (Flow Laboratories 
[catalog #76-401-05]) and centrifuged at 66 g for 10 rain at 4"C. The cells were 
then incubated  for 30 rain (tendon  flbroblasts) or 45 min (cardiac flbrnblasts) 
at 37"C. The wells were inverted  and centrifuged  again  at 66 g  to remove 
weakly adherent cells, the coversheets opened with a scalpel, and the superna- 
tant decanted.  The wells were then placed fight-side-up on a warm plate at 
2 Abbreviations  used  in  this  paper:  BrdU,  5-bromodeoxyuridine; 
CMF-PBS, calcium- and magnesium-free phosphate-buffered saline; 
CMF-HH, calcium- and magnesium-free HEPES-Hank's; DME, Dul- 
becco's modified Eagle's medium; TNC, 0.01  M  Tris, 0.5% Nonidet 
P-40; 0.5 mM CaCI2,  pH 8.0. 
37"C, and the adherent cells removed by trypsinization and counted. Analogous 
results  were  seen  using  nonadhesive  wells that were  not treated  for tissue 
culture. 
In experiments using uncoated  substrates, the assays were performed in the 
conditioned  medium derived from the original cell culture. Wells were coated 
with fibronectin (Collaborative Research, Waltham, MA, or Bethesda Research 
Laboratories,  Gaithersburg,  MD) by adding  10 ~1 from a stock solution  at a 
concentration  of I mg/ml fibronectin in 0.01 M CAPS buffer (cyclohexylami- 
nopropane sulfonic acid, pH 11; Sigma Chemical Co., St. Louis, MO) to each 
well and diluting to a total  volume of 1 ml with CMF-PBS. The wells were 
incubated for 2 h at 37"C, aspirated, and washed two times with CMF-PBS. 
Antigen Isolation:  Tendon or cardiac fibroblasts were grown to 80% 
confluency  in T-150  flasks, and the medium was removed.  The cells were 
washed three times with CMF-HH and then incubated  in  10.5 ml of methio- 
nine-free DME containing  0.1  ml/100 ml ITS (insulin, transferrin,  selenium; 
Collaborative  Research,  Lexington,  MA)  and  250  /~Ci of [3SS]methionine 
(1166.5  Ci/mM; New England  Nuclear,  Boston,  MA) for 6  h.  The growth 
medium was then removed, and the cells washed three times with CMF-HH 
and incubated  in CMF-HH containing  0.02% EDTA for 15-30 min at 37"C. 
The cells were harvested by scraping and resuspended into l ml of TNC (0.01 
M  "Iris, 0.5% Nonidet  P-40, 0.5  mM  CaCl2, pH  8.0)  containing  2  mM 
phenylmethylsuifonyl fluoride and allowed to sit on ice for 20 min. 
Affinity pudficaton followed the procedures described previously (21, 27), 
except that the column was eluted with 0.05 M diethylamine  in TNC at pH 
11.5.1 The samples were neutralized to pH 7.5 with I M HC1, dialyzed overnight 
at 4"C aganist TNC, concentrated  using polyethylene glycol (PEG 8,000; J. T. 
Baker Chemical Co., Phillipsburg, N  J) and Spectrapor tubing (3,500 molecular 
weight cut-off; Arthur H. Thomas Co., Philadelphia, PA), and diluted  l:l into 
0.07 M Tris-HCl, 2% SDS, 10% glycerol, and 5% 2-mcrcaptoethanol,  pH 6.8, 
heated  at  95"C for 3  min, run on  7%  SDS  polyacrylamide  gels (22), and 
visualized by fluorogmphy using EN3HANCE (New England Nuclear). 
Immunoprecipitations were performed  on the  Nonidet  P-40  cell extract 
using Immunobeads (rabbit anti-mouse  immunoglobulin;  Bio-Rad Laborato- 
ries, Richmond,  CA). The Immunobeads  were first washed three times in wash 
buffer (PBS at pH 7.6 containing  0.1% bovine serum albumin,  0.02% NAN3, 
and 0.5% Nonidet P-40) and resuspended to a stock solution  of l0 mg/ml. A 
0.2-ml  aliquot  of beads  was  then  blocked  by  incubating  with 0.2-0.4  ml 
unlabelled lysate for l h on ice followed by two washes with wash buffer. The 
labelled lysate was precleared by resuspending  2.0 mg of Immunobeads into 
0.2-0.4  ml of the Nonidet  P-40 cellular lysate and incubating  for l h on ice. 
The beads were pelleted, and the supernatant saved. 0.05-0.2  ml precleared 
lysate (0.75-8  x  l0  ~ cpm) was then incubated with the CSAT antibody  (3 pg) 
for 3 h on ice. It was then added to 2 mg of the blocked beads and allowed to 
incubate  for  1 h  on ice. The Immunobeads were  then  sedimented  in  the 
Eppendorf  centrifuge for 2 min and washed three times with wash buffer. The 
pellet was resuspended and transferred to a new centrifuge tube, and the beads 
washed one final time.  The supernatant was aspirated,  and the pellet resus- 
pended into 50 pl of 0.07 M Tris-HC1 (pH 8.6), 10% glycerol, 5% 2-mercap- 
toethanol,  and 3% SDS. The suspension was incubated  for 30 min at room 
temperature,  the beads sedimented,  and the supernatant heated  for 3 min at 
95°C and run on 7% SDS polyacrylamide gels (22) and visualized by fluorog- 
raphy using EN3HANCE (New England Nuclear). 
RESULTS 
A Comparison of the Effects of CSAT on the 
Morphology of Different Cell Types 
We have reported previously (27) that the addition of  CSAT 
to 2-d-old cultures derived from  10-11-d-old chick pectoral 
muscle explants induces a  rapid rounding of the myogenic 
cells;  nearly  all  of the  cells  are  round  and  either  weakly 
adherent or detached from the substratum (see also Fig.  2). 
The kinetics of this response is markedly dose dependent. At 
an antibody concentration of 20 pg/ml, morphologic changes 
are seen within 20-30 min. 
The effect of CSAT on the morphology of fibroblasts differs 
from that described for the myoblasts (Fig.  1).  The general 
effect is to  induce  a  retraction  of the  edges to  produce  a 
slightly less well spread morphology. The cardiac fibroblasts 
lie at one extreme; changes in their morphology, if they exist, 
are not detected by our methods. In skeletal fibroblasts, the 
effect is subtle, and while not readily apparent using phase 
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tures  were  seeded at a  density of 2-8  x  104 
cells/dish and grown for 16-96 h on uncoated 
35 mm tissue culture dishes. CSAT was added 
at a concentration of 10-50/tg/ml, and the cells 
were observed under modulation contrast op- 
tics 4-28  h  later.  Bar, 20 #m.  x  125.  Tendon: 
24-h tendon fibroblasts {third passage) in D/VIE 
containing 2% fetal calf serum.  Control is the 
same as +CSAT except that 20/~g/ml CSAT was 
added to the latter after 20 h in culture. Dermal: 
30-h dermal fibroblasts (primary cUltures) were 
grown in DME containing 10% fetal calf serum. 
Control  is the same as +CSAT except that 50 
/~g/ml CSAT was added to the latter after 24 h 
in culture. Skeletal: Skeletal fibroblasts (pass 6) 
were grown  in  DME  containing  5%  fetal  calf 
serum for  16 h. Control is the same as +CSAT 
except  for  the  presence  of  20  ttg/ml  CSAT 
added to the latter at the time of plating. Car- 
diac:  96-h  cardiac  fibroblasts  (pass  3)  were 
grown in DMEM containing 5% fetal calf serum. 
Control  is the same as +CSAT except that 20 
#g/ml CSAT was added to the latter after 72 h 
in culture. 
contrast,  it  can  be  seen  clearly  using  modulation  contrast 
optics (3,  15). Both confluent and nonconfluent cultures are 
affected. In the former, the cell outlines are particularly prom- 
inent, and, in the latter, the cells show a  clear retraction of 
edges.  This is most easily visualized in cells growing in low 
serum concentrations since they tend to be initially flatter on 
the dish. Few cells appear rounded and only a small fraction 
remain  fiat.  Plating  the  cells  in  the  presence  of antibody 
produces  the  same  morphology.  Fivefold  higher  antibody 
concentrations alter the  kinetics but  not  the  magnitude  of 
these effects.  The final morphology is apparent only after 2- 
6 h in antibody. 
The  effects of CSAT  on  the  morphology of tendon  and 
dermal fibroblasts, cardiac myocytes, and BrdU-treated skel- 
etal myoblasts, like those effects observed with the  skeletal 
flbroblasts, lie between the  two extremes just described for 
the skeletal myoblasts and cardiac fibroblasts (Figs.  1 and 2). 
When incubated with CSAT, they all appear less well spread. 
In contrast to the skeletal fibroblasts, the edges of  the majority 
of tendon  fibroblasts are more fully retracted,  and a  larger 
fraction of  the ceils are affected. An additional 20-40% appear 
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round, but they still remain weakly adherent to the substra- 
tum. Dermal fibroblasts respond analogously to tendon fibro- 
blasts except that their response decreases with each subse- 
quent passage. Tendon fibroblasts tend to reattach after ex- 
tended exposure to CSAT. There is some variability among 
different  cell preparations  in  their  response.  The  effect of 
CSAT also depends on serum concentration: cells growing in 
lower concentrations show larger effects. 
The response of cardiac myocytes is particularly striking 
(Fig. 2). They stand out as less well spread islands of synchron- 
ously contracting cells surrounded by the flatter, well-spread 
fibroblasts.  Like the  skeletal fibroblasts, the  morphological 
changes in the cardiac cells require at least 2-6-h incubation. 
The  altered morphology and  synchronous contractions are 
apparent in cultures plated in the presence of antibody, and 
they persist for at least 9 d  in the presence of antibody. The 
original  morphology returns  to  that  of the  control  upon 
removal of the  antibody.  When  plated  in  the  presence of 
antibody, a large population of cells do not plate as rapidly as 
do  the  others.  If these  suspended  cells  are  harvested  and 
replated, they form cultures highly enriched in synchronously FIGURE  2  Effect of CSAT on myogenic cells. 
Cultures were seeded at a  density of 3-5  x 
10  s cells on 0.1% gelatin coated 35-ram  tis- 
sue-culture dishes. The cells were grown for 
24-68 h in DME containing 10% horse serum 
and  1%  conalbumin. CSAT was added at a 
concentration of 10-20/~g/ml, and the cells 
observed  under  phase-contrast or  modula- 
tion contrast optics 4-24 h later. Bar,  40 #m. 
Skeletal: 72-h skeletal myoblasts grown in the 
presence of  1.35  mM  EG1-A. Control is the 
same as +CSAT  except for the presence of 
20/~g/ml CSAT added to the latter after 44 h 
in culture,  x  75.  Cardiac: 48-h  cardiac my- 
oblasts. Control is the same as +CSAT, except 
for the addition of 10 ,g/ml of CSAT to the 
latter  after  24  h  in  culture,  x  150. BrdU- 
treated skeletal myoblasts: 72-h BrdU-treated 
myoblasts (1.6 x  10  -4 M). Control is the same 
as +CSAT,  except for the presence of 20 #g/ 
ml CSAT added to  the  latter after 68  h  in 
culture, x  150. 
contracting cells. The cells remaining on the original dish are 
enriched in fibroblast-like cells. 
Effect of Calcium and Time in Culture on 
CSA  T Action 
Some effects of CSAT on morphology depend on culture 
age and calcium concentration. We previously reported that 
skeletal myoblasts, when  grown  in  a  low calcium  medium 
(0.4 mM) through at least 5 d in culture, are rapidly rounded 
by CSAT (27).  In contrast, cultures grown in normal calcium 
concentrations (2.0  raM) display age dependent changes in 
their  response  to  CSAT.  Young,  24--48  hour  cultures  are 
readily rounded,  whereas older cultures require higher con- 
centration of antibody and longer incubation times. 
BrdU-treated skeletal myoblasts, replicating putative my- 
ogenic  precursors,  respond  to  CSAT  analogously.  When 
grown  in  a  low calcium  medium,  for 24-96  h,  the  BrdU- 
treated myoblasts are rounded by CSAT.  In contrast,  older 
(72-96  h) cultures grown in  normal calcium levels are  not 
rounded but display the less well spread morphology. Fewer 
than  10%  of the  cells display a  round  morphology. When 
normal calcium levels are restored to 72-h cultures simulta- 
neously  with  antibody  addition,  the  cells  are  no  longer 
rounded by the antibody. 
Adhesive Alterations  Parallel the 
Morphologic Changes 
The different morphologic effects of CSAT just described 
imply differences in the adhesion of these cell types. This can 
be demonstrated, for weakly adherent cells, by gently washing 
the cell cultures and counting the fraction of cells detached. 
Although the results depend on the number of pipettings and 
their force, once a procedure is established the determinations 
are reproducible. Using this assay we find that 48-h skeletal 
myoblast cultures adhere more weakly and slowly than do the 
skeletal fibroblasts (not shown); this difference has been used 
previously  to  fractionate  myogenic  from  fibrogenic  ceils. 
Among BrdU-treated skeletal  myoblasts grown  for varying 
lengths  of time  in  culture,  we  find  that  the  ratios  of the 
fraction of cells removed in CSAT-treated cultures grown for 
48, 72, and 96 h is 13:5:1. The assay also reveals that six times 
as  many 48-h  skeletal  myoblasts and  four  times as  many 
BrdU-treated  skeletal  myoblasts  are  removed  after  CSAT 
treatment  (20  #g/ml  for  3-4  h)  as  are  skeletal  fibroblasts. 
These differences are  pairwise  statistically  significant  (P < 
0.025) and parallel the relative degree of morphologic change 
described above. 
We developed a more quantitative assay of cell substratum 
adhesion that measures the initial binding events. This assay, 
based on  that  described by McClay et  al.  (25)  for cell-cell 
adhesion,  allows estimates of adhesive strength  to different 
substrata. Cells from subconfluent cultures are removed with 
EDTA and added to tissue culture microwells, gently centri- 
fuged to  bring  the  cells  into  contact  with  the  substratum, 
incubated for 20--45 min, inverted, the weakly adherent cells 
sedimented  off  the  substratum,  and  the  remaining  cells 
counted. We used this assay to explore the adhesion of  tendon 
skeletal and cardiac fibroblasts, cell types that show different 
responses to CSAT. These cells adhere best when incubated 
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containing an adhesion-promoting matrix molecule like fibro- 
nectin.  The  fraction  of  cells  adhering  to  the  substratum 
reaches  a  plateau  after  ~30-45  min  under  the  conditions 
described here. 
Fig.  3 shows the adhesion of tendon, skeletal, and cardiac 
fibroblasts in  the  presence of conditioned medium and in- 
creasing concentrations of CSAT antibody. The adhesion of 
the tendon fibroblasts is inhibited ~90%  by  10 #g/ml anti- 
body. Half maximal inhibition occurs at an antibody concen- 
tration of-  1-2  ~g/ml. The adhesion  of skeletal myoblasts 
shows a superimposable inhibition (data not shown). In con- 
trast, the skeletal fibroblasts and cardiac fibroblasts are not 
inhibited half maximally even at 50-100-fold higher antibody 
concentrations. The modest inhibitions that do occur appear 
to  result  from a  susceptible  subpopulation  of cells in  the 
culture.  These  patterns  of adhesive  inhibition  parallel  the 
morphologic description of CSAT action:  tendon fibroblast 
cultures are rounded by the antibody, and the cells remain 
only weakly adherent to the substratum; skeletal and cardiac 
fibroblasts show only modest morphologic effects of the an- 
tibody and remain adherent. 
Since the conditioned medium may contain many different 
INHIBITION OF ATTACHMENT BY CSAT 
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FIGURE 3  Concentration dependence of  inhibition of fibroblast 
adhesion by CSAT. 48-h cultures  of tendon, skeletal,  or cardiac 
fibroblasts were harvested with EDTA, resuspended into their con- 
ditioned culture  medium, and  centrifuged onto  multiwells. The 
wells were incubated for 30 min (tendon and skeletal fibroblasts) 
or 45  min  (cardiac  fibroblasts)  at  37°C,  the wells  inverted, the 
weakly adherent cells sedimented off at 66 g, and the remaining 
cells counted. The data  are averages of two to six independent 
determinations. They are expressed as averages with standard de- 
viation of the percent control attachment which is defined as the 
fraction of adherent cells  times  100  divided  by  the  number of 
adherent cells with no antibody present. 35-45% of the cells were 
attached in the no-antibody control wells. 
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adhesion-promoting constituents, the adhesion to fibronectin, 
a defned adhesion promoting substratum, was studied (19, 
29,  33-35).  Both tendon and cardiac fibroblasts adhere to 
fibronectin-coated substrates. The adhesion of tendon fibro- 
blasts to fibronectin was inhibited -70% when CSAT (20 ~g/ 
ml) was included in the assay: i.e., 51 ±  13% vs.  16 ± 9% of 
the ceils initially added to the wells adhered in the absence 
and presence of antibody, respectively. In contrast, cardiac 
fibroblast adhesion was only slightly inhibited (-10%): 35 ± 
14% vs. 32% +__ 10% adhesion. Similar results were seen after 
a  5-h pretreatment with 25 gg/ml cyclohexamide: 48 ±  9% 
vs.  17 +__ 3% for the tendon fibroblasts and 25 ± 9% vs. 20 ± 
3% for the cardiac fibroblasts. 
These observations show that the differential responses of 
tendon and cardiac fibroblast cultures to CSAT are also seen 
in assays  of the initial binding to fibronectin. This suggests 
that the differential responses to CSAT reside, at least in part, 
in the cell surfaces of the cell types themselves rather than in 
differences in the substrata to which they may be adhering. 
Antigen Comparison 
Neffet al. (27) reported previously that the antigen purified 
by CSAT affinity chromatography from skeletal muscle ran 
as a broad band in the molecular weight range of 120,000- 
160,000  on SDS polyacrylamide gels. Polyclonal antibodies 
raised against this material detach myoblasts at high dilutions 
demonstrating  the  presence  of the  CSAT  antigen  in  this 
molecular weight region (17). 
The affinity-purified antigen isolated from tendon and car- 
diac fibroblasts, two cell types that respond differentially to 
CSAT, show indistinguishable patterns on SDS polyacrylam- 
ide gels (Fig. 4). These patterns are also indistinguishable from 
FIGURE 4  Visualization of CSAT antigen from tendon and cardiac 
fibroblasts  on SDS PAGE. Affinity purified or immunoprecipitated, 
35S-labelled  antigen was run on 7% SDS PAGE slab gels and visu- 
alized by autoradiography. Lanes  A-D: immunoprecipitated  antigen 
from tendon (A and B) and cardiac  (C and D) fibroblasts.  Lanes  A 
and  C  immunoprecipitated with  CSAT; lanes  B and  D  control 
immunoprecipitation without  CSAT. Lanes E-F:  affinity  purified 
antigen from tendon (E) and cardiac (F) fibroblasts. that reported previously for the skeletal fibroblasts and from 
skeletal myoblasts (not shown). We also isolated the antigen 
by immunoprecipitation using the CSAT monoclonal anti- 
body. This procedure omits the precipitation steps used in the 
affinity purification and may reveal co-purification of other 
proteins that might be associated with the CSAT antigen (Fig. 
4).  The antigen  isolated from both cell types show similar 
electrophoretic patterns. In some experiments an additional 
band was observed in the 170,000-mol-wt range. The molec- 
ular weight of this band was consistently lower in the cardiac 
fibroblasts.  The  significance of this  auxiliary band,  if any, 
remains to be determined. 
DISCUSSION 
The  availability of monoclonal  antibodies  directed  against 
adhesion-related  membrane  proteins  allows  investigations 
into their general presence and role in the adhesion of embry- 
onic and adult cell types. The experiments reported here are 
the  initial  observations from such  a  study  using  CSAT,  a 
monoclonal antibody that was first identified by its inhibition 
of the adhesion of embryonic skeletal muscle to extracellular 
matrices. The effects of CSAT on the cell types investigated 
here  demonstrate  a  somewhat  general  role  for  the  CSAT 
antigen in cell-matrix adhesion. 3 The antigen participates in 
the matrix adhesion of different types of muscle and fibro- 
blasts; however, its contribution to their adhesion is different. 
Whereas the antibody dramatically perturbs the adhesion and 
morphology of skeletal myoblasts and tendon fibroblasts, its 
effect on cardiac fibroblast adhesion and morphology is sub- 
stantially less. The other cell types appear to lie between these 
two extremes. We interpret these observations as revealing a 
hierarchy of adhesive and morphologic complexity. 
The  molecular  origin  of this  hierarchy  is  of particular 
interest.  The nearly identical binding affinities of CSAT to 
skeletal fibroblasts and myoblasts (27), along with the similar 
SDS  PAGE  profiles of antigen  purified  from tendon  and 
cardiac  fibroblasts,  suggests  that  CSAT  is  interacting  with 
similar if not identical antigens on these different cells. Bind- 
ing studies on myoblasts, myotubes, and skeletal fibroblasts, 
along with the similar intensity of fluorescent staining on the 
other cells studied here, suggests that they all possess a similar 
antigen density (27). However, 50-100-fold increases in anti- 
body concentration  neither  round  nor inhibit  substantially 
the adhesion of cardiac and skeletal fibroblasts. Thus adhesive 
differences arising solely as the result of different amounts of 
CSAT antigen on these different cell types is unlikely. Finally, 
our observations that the adhesive differences are seen with 
tendon and cardiac fibroblasts plated onto a  common sub- 
strate, i.e.,  fibronectin, further suggest that the adhesive hier- 
archy also does not arise solely from differences in extracel- 
lular materials. 
The  presence  of additional,  different  kinds  of adhesion 
related molecules provides a more likely explanation for the 
differential responses to CSAT. In this interpretation, there 
exists a repertoire of molecules that participate in cell-matrix 
adhesion.  The adhesion of any one cell type is then deter- 
3  Despite the clear participation of the CSAT antigen in the adhesion 
of different cell types to extracellular matrices, we have no evidence 
implicating it in cell-cell adhesion. Neither myoblast fusion (27) nor 
the synchronous beating of cardiac cells are impaired detectably by 
antibody treatment. 
mined by the members of the repertoire that are present on 
it. 4 The skeletal myoblast would  represent one extreme.  It 
uses only a small fraction of the repertoire, and hence it is a 
weakly adherent  cell and  highly responsive to  CSAT.  The 
cardiac fibroblast, in contrast, represents the other extreme. 
It uses a relatively large number of different adhesive mole- 
cules.  Therefore,  it  is  more  strongly  adherent  and  is  not 
responsive to the presence of CSAT. 
Further evidence for a multiplicity of adhesion molecules 
is also found in the work of others. Harper and Juliano (14) 
have described variants of Chinese hamster ovary cells that 
no  longer adhere  to  fibronectin  but  do  adhere  to  a  more 
complex substratum.  Interference reflection and immunoe- 
lectron  microscopy reveal  several morphologically distinct 
kinds of putative cell-matrix adhesion sites (6,  20).  One of 
these,  the  focal  contact,  is  the  locus  of shortest  distance 
between the cell and substratum and is the site of stress fiber 
termination;  when  present,  it corresponds to the  strongest 
adhesive structure (l, 6, 20).  Recently, Oech and Birchmeier 
(28) have described an adhesion-perturbing monoclonal an- 
tibody that localizes in the region of the focal contact. This 
localization and the molecular weight of the antigen distin- 
guish it from the CSAT antigen. 
Thus a picture of cell-substrate adhesion emerges in which 
more than  one  kind  of adhesive  molecule or  complex of 
adhesive molecules mediates the adhesion of cells to extracel- 
lular matrices.  In weakly adherent  ceils,  for example, one 
anticipates that one or a very small number of different kinds 
of adhesion-related  molecules would  dominate  with  other 
members of the  repertoire either absent  or present  in  low 
concentrations. Strongly adherent cells, in contrast, would use 
additional  members of the  repertoire.  The presence of the 
CSAT antigen on all of the cells studied thus far suggests that 
it is a lowest common denominator of matrix adhesion and 
that the hierarchy is not fully combinatoric. In this way, the 
adhesive differences of different cell types reflects a molecular 
hierarchy  on  these  cells;  that  is the  progressive display of 
additional kinds of  adhesion-related molecules on increasingly 
more adhesive cells forms a nested set of molecular determi- 
nants. 
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